Helixtalk - Rosalind Franklin University's College Of Pharmacy Podcast
067 - Diabetes: does it cost a “heart” and a leg?
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:28:21
- Mais informações
Informações:
Sinopse
In this episode, we discuss new evidence for cardiovascular outcomes in diabetics based on the LEADER trial (liraglutide) and CANVAS trials (canagliflozin). We also discuss the new FDA warning for canagliflozin regarding amputation risk.
